Covid-19: UK approves Novavax’s protein based vaccine
Author:
- 4 February 2022
- news
- Published by BMJ
- Vol. 376, o309
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Immunogenicity and Safety Following a Homologous Booster Dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): A Phase 2 Randomized Placebo-Controlled TrialmedRxiv, 2021
- Covid-19: Whatever happened to the Novavax vaccine?BMJ, 2021
- Safety and Efficacy of NVX-CoV2373 Covid-19 VaccineNew England Journal of Medicine, 2021